These findings suggest that survodutide has the potential to reduce liver fibrosis and improve liver function in patients with NASH, making it a promising therapeutic option for this complex liver disease [89]
For comparison, in the table below, we also show those GLP-1 agonists with active ingredients only approved for treatment of diabetes that have less potential for off-label weight loss use (Bydureon BCise, Trulicity)
Subscribe to my free weekly newsletter you'll be the first to know when I add new printable documents and templates to the FreePrintable.net network of sites
The medication should not be frozen and should remain in its original carton to protect it from light
These veggies not only keep meals interesting but also support digestion and help with that all-important fiber intake
Finally, the biology of non-response and therapeutic resistance - including the role of gut microbiome composition, adipose tissue dysfunction phenotypes, and genetic determinants of drug metabolism - represents a frontier for translational investigation to improve patient outcomes